← Back to Patent Explorer
US3963613A Expired / Lapsed US ⏱️ 0.0 years remaining

Blood purification means

Assignee: Tanabe Pharma Corp
•
Filing: 1974-12-26
•
Granted: 1976-06-15
•
Expires: 1994-12-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A blood purification means whereby blood of a patient to be treated is led around an external circuit connecting to the patient's blood stream and is brought into direct or indirect contact with a fumarate solution, and is further brought into direct or indirect contact with an enzymic preparation, which is suitably an aspartase preparation, which catalyzes a reaction of L-aspartic acid formation from fumaric acid and ammonia. The purification means may further include a preliminary stage or stages whereat an unrequired substance in a patient's blood is decomposed to a non toxic substance and ammonia subsequently convertable to aspartic acid, and may also include a low molecular sieve means preventing re-entry of aspartic acid produced into the patient's blood stream.

Inventors

  • 👤 Ichiro Chibata
  • 👤 Tetsuya Tosa
  • 👤 Takao Mori

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 17:07
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/022; A61M; A61M1/00; A61M1/14; A61M1/16; A61M1/1694; A61M1/1696; A61M1/36; A61M1/3687

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 144 words
A blood purification means comprising a first cannula circuit for transport of blood having both ends which are adapted to be connected to the blood stream of a patient to be treated, a hemodialysis unit having a first dialysate provided in said first circuit, the first dialysate being effected with the blood of said first cannula circuit through a semi-permeable membrane, a second cannula circuit for transport of the first dialysate of said hemodialysis unit having both ends connected to said hemodialysis unit, a dialyzer having a second dialysate provided in said second cannula circuit, the second dialysate containing additions of fumarate and an aspartase preparation and being selectively effected with said first dialysate through a semipermeable membrane which permits diffusion therethrough of ammonia molecules, but not of aspartic acid molecules, and a pump for driving said first dialysate around said second cannula circuit.
Claim 2
Dependent Claim 144 words
A blood purification means comprising a first cannula circuit for transport of blood having both ends which are adapted to be connected to the blood stream of a patient to be treated, a hemodialysis unit having a first dialysate provided in said first circuit, the first dialysate being effected with the blood of said first cannula circuit through a semi-permeable membrane, a second cannula circuit for transport of the first dialysate of said hemodialysis unit having both ends connected to said hemodialysis unit, a dialyzer having a second dialysate provided in said second cannula circuit, the second dialysate containing additions of fumarate and an aspartase preparation and being selectively effected with said first dialysate through a semipermeable membrane which permits diffusion therethrough of ammonia molecules, but not of aspartic acid molecules, and a pump for driving said first dialysate around said second cannula circuit.
Claim 3
Dependent Claim 148 words
A blood purification means comprising a first cannula circuit for transport of blood having both ends which are adapted to be connected to the blood stream of a patient to be treated, a hemodialysis unit having a first dialysate provided in said first circuit, the first dialysate containing an asparaginase preparation and being effected with the blood of said first cannula circuit through a semipermeable membrane, a second cannula circuit for transport of the first dialysate of said hemodialysis unit having both ends connected to said hemodialysis unit, a dialyzer having a second dialysate provided in said second cannula, the second dialysate containing additions of fumarate and an asparaginase preparation and being selectively effected with said first dialysate through a semipermeable membrane which permits diffusion therethrough of ammonia molecules, but not of aspartic acid molecules, and a pump for driving said first dialysate around said second cannula circuit.
Claim 4
Dependent Claim 148 words
A blood purification means comprising a first cannula circuit for transport of blood having both ends which are adapted to be connected to the blood stream of a patient to be treated, a hemodialysis unit having a first dialysate provided in said first circuit, the first dialysate containing an asparaginase preparation and being effected with the blood of said first cannula circuit through a semipermeable membrane, a second cannula circuit for transport of the first dialysate of said hemodialysis unit having both ends connected to said hemodialysis unit, a dialyzer having a second dialysate provided in said second cannula, the second dialysate containing additions of fumarate and an asparaginase preparation and being selectively effected with said first dialysate through a semipermeable membrane which permits diffusion therethrough of ammonia molecules, but not of aspartic acid molecules, and a pump for driving said first dialysate around said second cannula circuit.

References Cited (Backward Citations)

US3794584A Cited
US3619423A Cited
US3727612A Cited
US3839200A Cited
US3809613A Cited
US3791926A Cited
US3865726A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-06-15 1979-12-15 1980-06-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-06-15 1983-12-15 1984-06-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-06-15 1987-12-15 1988-06-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag